92 related articles for article (PubMed ID: 25731712)
1. ER egress of invariant chain isoform p35 requires direct binding to MHCII molecules and is inhibited by the NleA virulence factor of enterohaemorrhagic Escherichia coli.
Cloutier M; Gauthier C; Fortin JS; Genève L; Kim K; Gruenheid S; Kim J; Thibodeau J
Hum Immunol; 2015 Apr; 76(4):292-6. PubMed ID: 25731712
[TBL] [Abstract][Full Text] [Related]
2. The invariant chain p35 isoform promotes formation of nonameric complexes with MHC II molecules.
Cloutier M; Gauthier C; Fortin JS; Thibodeau J
Immunol Cell Biol; 2014 Jul; 92(6):553-6. PubMed ID: 24638068
[TBL] [Abstract][Full Text] [Related]
3. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
Khalil H; Brunet A; Thibodeau J
J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
[TBL] [Abstract][Full Text] [Related]
4. The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal.
Khalil H; Brunet A; Saba I; Terra R; Sékaly RP; Thibodeau J
Int Immunol; 2003 Oct; 15(10):1249-63. PubMed ID: 13679394
[TBL] [Abstract][Full Text] [Related]
5. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice.
Genève L; Chemali M; Desjardins M; Labrecque N; Thibodeau J
Immunol Cell Biol; 2012 Oct; 90(9):896-902. PubMed ID: 22689013
[TBL] [Abstract][Full Text] [Related]
6. The human-specific invariant chain isoform Iip35 modulates Iip33 trafficking and function.
Sand KM; Landsverk OJ; Berg-Larsen A; Bakke O; Gregers TF
Immunol Cell Biol; 2014 Oct; 92(9):791-8. PubMed ID: 24983457
[TBL] [Abstract][Full Text] [Related]
7. Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation.
Kuwana T; Peterson PA; Karlsson L
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1056-61. PubMed ID: 9448284
[TBL] [Abstract][Full Text] [Related]
8. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain.
Arunachalam B; Lamb CA; Cresswell P
Int Immunol; 1994 Mar; 6(3):439-51. PubMed ID: 8186195
[TBL] [Abstract][Full Text] [Related]
9. The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers.
Cloutier M; Fortin JS; Thibodeau J
BMC Immunol; 2021 Aug; 22(1):56. PubMed ID: 34384367
[TBL] [Abstract][Full Text] [Related]
10. The p35 human invariant chain in transgenic mice restores mature B cells in the absence of endogenous CD74.
Genève L; Ménard C; Labrecque N; Thibodeau J
Int Immunol; 2012 Oct; 24(10):645-60. PubMed ID: 22966065
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments.
Anderson HA; Bergstralh DT; Kawamura T; Blauvelt A; Roche PA
J Immunol; 1999 Nov; 163(10):5435-43. PubMed ID: 10553069
[TBL] [Abstract][Full Text] [Related]
12. Assembly of major histocompatibility complex class II subunits with invariant chain.
Neumann J; Koch N
FEBS Lett; 2005 Nov; 579(27):6055-9. PubMed ID: 16242130
[TBL] [Abstract][Full Text] [Related]
13. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
Vigna JL; Smith KD; Lutz CT
J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
[TBL] [Abstract][Full Text] [Related]
14. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
Lamb CA; Cresswell P
J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
[TBL] [Abstract][Full Text] [Related]
15. The intracellular localization and oligomerization of chicken invariant chain with major histocompatibility complex class II subunits.
Ye H; Xu FZ; Yu WY
Poult Sci; 2009 Aug; 88(8):1594-600. PubMed ID: 19590073
[TBL] [Abstract][Full Text] [Related]
16. Impaired processing and presentation by MHC class II proteins in human diabetic cells.
Yan G; Shi L; Penfornis A; Faustman DL
J Immunol; 2003 Jan; 170(1):620-7. PubMed ID: 12496451
[TBL] [Abstract][Full Text] [Related]
17. Cross-species association of quail invariant chain with chicken and mouse MHC II molecules.
Chen F; Wu C; Pan L; Xu F; Liu X; Yu W
Dev Comp Immunol; 2013 May; 40(1):20-7. PubMed ID: 23370168
[TBL] [Abstract][Full Text] [Related]
18. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
Thayer WP; Ignatowicz L; Weber DA; Jensen PE
J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
[TBL] [Abstract][Full Text] [Related]
19. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
20. An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum.
Schutze MP; Peterson PA; Jackson MR
EMBO J; 1994 Apr; 13(7):1696-705. PubMed ID: 8157008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
